Preclinical Research


Charles River to buy MPI Research for $800m

By Flora Southey

Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.

(Image: Getty/Artem_Egorov)

Metrion secures funding to advance preclinical work

By Melissa Fassbender

The ion channel contract research and drug discovery company has been awarded £200,000 ($278,910) to develop its drug discovery pipeline – in-house and with UK-based CROs.